Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Current Leases (2023 - 2026)

Camp4 Therapeutics (CAMP) posted Current Leases of $384000.0 for Q1 2026, up 34.27% sequentially from $286000.0 in Q4 2025, and down 87.49% YoY from $3.1 million in Q1 2025.

Analysis

Camp4 Therapeutics (CAMP) Current Leases (2023 - 2026) Analysis & Trends

Camp4 Therapeutics has reported Current Leases for 4 years, with the latest figure at $384000.0 in Q1 2026.

  • Quarterly Current Leases fell 87.49% year-over-year to $384000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $384000.0 (down 87.49% YoY) and the FY2025 annual result came in at $286000.0, down 90.45% from the prior year.
  • Current Leases improved to $384000.0 in Q1 2026 per CAMP's latest filing, from $286000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $3.1 million in Q2 2025 and troughed at $27000.0 in Q3 2025.
  • A 4-year average of $1.6 million and a median of $1.7 million in 2024 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2024 and 2025: Current Leases jumped 745.76% in 2024, then plunged 99.08% in 2025.
  • Over 4 years, Current Leases stood at $354000.0 in 2023, then surged by 745.76% to $3.0 million in 2024, then sank by 90.45% to $286000.0 in 2025, then jumped by 34.27% to $384000.0 in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $384000.0, $286000.0, and $27000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - 802,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 802,000.00
Mar 31, 2026 384,000.00
Dec 31, 2025 286,000.00
Sep 30, 2025 3.23 Mn
Jun 30, 2025 3.15 Mn
Mar 31, 2025 3.07 Mn
Dec 31, 2024 2.99 Mn
Sep 30, 2024 2.92 Mn
Dec 31, 2023 2.70 Mn